Zyvox 600 mg Film-Coated Tablets

  • Name:

    Zyvox 600 mg Film-Coated Tablets

  • Company:
    info
  • Active Ingredients:

    Linezolid

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 06/09/17

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 7/9/2017
print

Print ViewKeyword Search SmPC

Pfizer Healthcare Ireland

Pfizer Healthcare Ireland

Company Products

Medicine NameActive Ingredients
Medicine Name Lipitor 10 mg film-coated tablets Active Ingredients Atorvastatin calcium trihydrate
Medicine Name Lipitor 20mg Chewable Tablets Active Ingredients Atorvastatin calcium trihydrate
Medicine Name Lipitor 20mg film-coated tablets Active Ingredients Atorvastatin calcium trihydrate
Medicine Name Lipitor 40mg film-coated tablets Active Ingredients Atorvastatin calcium trihydrate
Medicine Name Lipitor 80mg film-coated tablets Active Ingredients Atorvastatin calcium trihydrate
Medicine Name Loniten 5 mg Tablets Active Ingredients Minoxidil
Medicine Name LOPID 300MG CAPSULES Active Ingredients Gemfibrozil
Medicine Name Lopid 600 mg film-coated tablet Active Ingredients Gemfibrozil
Medicine Name Lorviqua 25mg & 100mg Film Coated Tablets Active Ingredients Lorlatinib
Medicine Name LUSTRAL 100 mg film coated tablets Active Ingredients sertraline hydrochloride
Medicine Name LUSTRAL 50mg film coated tablets Active Ingredients sertraline hydrochloride
Medicine Name LYRICA Capsules Active Ingredients pregabalin
Medicine Name Meronem I.V. 1g Active Ingredients Meropenem Trihydrate
Medicine Name Methotrexate 1 g/10 ml Injection Active Ingredients Methotrexate Sodium
Medicine Name Methotrexate 10 mg Tablets Active Ingredients Methotrexate
Medicine Name Methotrexate 2.5mg Tablets Active Ingredients Methotrexate
Medicine Name Methotrexate 5 g/50 ml Injection Active Ingredients Methotrexate Sodium
Medicine Name Methotrexate 5 mg/2 ml Injection Active Ingredients Methotrexate Sodium
Medicine Name Methotrexate 50 mg/2 ml Injection Active Ingredients Methotrexate
Medicine Name Methotrexate 500 mg/20 ml Injection Active Ingredients Methotrexate Sodium
Medicine Name Minulet 75 micrograms/30 micrograms Coated Tablets Active Ingredients Ethinylestradiol, Gestodene
Medicine Name Mitoxantrone 2 mg/ml Concentrate for Solution for Infusion Active Ingredients Mitoxantrone hydrochloride
Medicine Name Mycobutin Capsules Active Ingredients Rifabutin
Medicine Name MYLOTARG 5mg powder for concentrate for solution for infusion Active Ingredients Gemtuzumab ozogamicin
Medicine Name Neurontin 100mg Hard Capsules Active Ingredients Gabapentin
126 - 150 of 231 items.Total: 10 pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 7 September 2017 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 7 September 2017 SmPC

Reasons for updating

  • Correction of spelling/typing errors

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC is updated with spacing and typo corrections.

Updated on 6 September 2017 PIL

Reasons for updating

  • New PIL for new product

Updated on 6 September 2017 PIL

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Updated on 4 July 2016 SmPC

Reasons for updating

  • Change to section 3 - Pharmaceutical form
  • Change to section 6.1 - List of excipients

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows: change to tablet description in section 3 and removal of printing ink excipients from section 6.1.

Updated on 1 July 2016 PIL

Reasons for updating

  • Change to date of revision
  • Change to appearance of the medicine

Updated on 28 June 2016 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 6.1 - List of excipients
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows:

Editorial, formatting and QRD changes to section 1, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 5.1, 5.2, 5.3, 6.1, 6.4, 6.5, 6.6, 10

Updated on 27 June 2016 PIL

Reasons for updating

  • Change of manufacturer
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about missed dose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to date of revision
  • Addition of manufacturer
  • Change of special precautions for disposal
  • Correction of spelling/typing errors

Updated on 15 June 2016 PIL

Reasons for updating

  • Change of manufacturer
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about missed dose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to date of revision
  • Addition of manufacturer
  • Change of special precautions for disposal
  • Correction of spelling/typing errors

Updated on 15 June 2016 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 6.1 - List of excipients
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows:

Editorial, formatting and QRD changes to section 1, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 5.1, 5.2, 5.3, 6.1, 6.4, 6.5, 6.6, 10

Updated on 27 August 2015 PIL

Reasons for updating

  • Addition of manufacturer

Updated on 17 July 2015 PIL

Reasons for updating

  • Addition of manufacturer

Updated on 13 October 2014 SmPC

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to section 4.6 - Pregnancy and lactation

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Section 4.6 – Fertility, pregnancy and lactation: added wording Fertility In animal studies, linezolid caused a reduction in fertility (see section 5.3).

Section 4.8 Undesirable effects updated in relation to the frequency of side effects

Updated on 8 October 2014 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision

Updated on 9 July 2013 SmPC

Reasons for updating

  • New individual SPC (was previously included in combined SPC)

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

None provided

Updated on 26 April 2013 PIL

Reasons for updating

  • Change of manufacturer

Updated on 27 February 2013 PIL

Reasons for updating

  • Change to date of revision
  • Improved electronic presentation

Updated on 6 February 2013 PIL

Reasons for updating

  • Change of licence holder
  • Change to date of revision
  • Change to marketing authorisation holder

Updated on 18 October 2011 PIL

Reasons for updating

  • Change to marketing authorisation holder

Updated on 23 June 2011 PIL

Reasons for updating

  • Change to side-effects
  • Change to information about driving or using machinery

Updated on 4 December 2009 PIL

Reasons for updating

  • Change to side-effects

Updated on 28 July 2009 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions

Updated on 20 November 2008 PIL

Reasons for updating

  • Change due to user-testing of patient information

Updated on 14 August 2008 PIL

Reasons for updating

  • Correction of spelling/typing errors

Updated on 18 May 2007 PIL

Reasons for updating

  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 15 January 2007 PIL

Reasons for updating

  • Change to marketing authorisation holder

Updated on 22 June 2005 PIL

Reasons for updating

  • Change to side-effects

Updated on 4 November 2004 PIL

Reasons for updating

  • New PIL for medicines.ie